國家衛生研究院 NHRI:Item 3990099045/15578
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 908436      Online Users : 990
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/15578


    Title: Predicting hemorrhagic transformation and malignant brain edema after reperfusion therapy: The tole of endothelin-1
    Authors: Huang, JA;Chang, KC;Chen, PL;Wu, YH;Chou, WH
    Contributors: Center for Neuropsychiatric Research
    Abstract: Background and Aims: Reperfusion therapies may increase hemorrhagic transformation (HT) and worsen brain edema in acute ischemic stroke. Our objective is to predict HT or malignant brain edema before and after reperfusion therapy by analyzing serum endothelin-1 (ET-1). Methods: We hypothesize that serum ET-1 levels: 1) increase early in response to cerebral ischemia before therapy and increase to a greater extent after reperfusion therapy; and 2) correlate with HT or malignant brain edema. We proposed a cross-sectional cohort study. Acute ischemic strokes were diagnosed by neurologist and supported by CT scan. The patients were eligible for intravenous administration of rtPA in 4.5 hours and for mechanical thrombectomy (EVT) in 6 hours after symptom onset according to predefined protocols in a comprehensive stroke center in Taiwan. We measured serum ET-1 levels by ELISA. Results: We enrolled 29 patients 20 years or older who underwent reperfusion therapy. The mean age was 67 years. The number of males was 12. Of 29 patients, 8 patients received rtPA, 18 patients underwent EVT, and 3 patients were treated with both. After reperfusion therapy, HT occurred in 13 patients and malignant brain edema developed in 5 patients. There was a non-significant trend that serum ET-1 levels were higher in patients with HT or malignant brain edema (127.0±49.7 ng/mL) than in patients without HT and malignant brain edema (111.0.0±50.6 ng/mL). Conclusions: The serum ET-1 level is a potential biomarker for predicting HT and malignant brain edema after reperfusion therapy in acute ischemic stroke.
    Date: 2023-10-10
    Relation: International Journal of Stroke. 2023 Oct 10;18(3):298.
    Link to: http://dx.doi.org/10.1177/1747493023119201
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1747-4930&DestApp=IC2JCR
    Appears in Collections:[Wen-Hai Chou] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI001094858601248.pdf132KbAdobe PDF82View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback